Please use this identifier to cite or link to this item:
Title: Can magnetic resonance imaging solve the prostate cancer conundrum?
Epworth Authors: Grummet, Jeremy
O'Sullivan, Richard
Keywords: Multiparametric Magnetic Resonance Imaging
Prostate Cancer
Prostate-Specific Antigen Testing
Diagnostic Test
Healthcare Imaging, Epworth Hospital, Victoria, Australia
Issue Date: May-2015
Citation: Med J Aust. 2015 May 4;202(8):410-1.
Abstract: The debate about prostate-specific antigen (PSA) testing for the diagnosis of prostate cancer continues to rage. The United States Preventive Services Task Force (USPSTF) and the equivalent Canadian body have both advised against PSA screening.1,2 On the other hand, many authoritative bodies, including the American Urological Association,3 the National Comprehensive Cancer Network (US), the American Cancer Society, the European Association of Urology,4 and our own Urological Society of Australia and New Zealand recommend that, instead of population-based screening, decisions about PSA testing of men aged 55–69 years should be shared by doctors and individual patients. A diagnostic test, that can detect significant prostate cancer, but can exclude indolent disease, has therefore been desperately needed. Multiparametric magnetic resonance imaging (mpMRI) may turn out to be that test.
DOI: 10.5694/mja14.01362
PubMed URL:
ISSN: 0025-729X
Journal Title: Medical Journal of Australia
Type: Journal Article
Appears in Collections:Cancer Services
Diagnostic Services
UroRenal, Vascular
Epworth Prostate Centre

Files in This Item:
There are no files associated with this item.

Items in EKB are protected by copyright, with all rights reserved, unless otherwise indicated.